This Article Full Text Full Text (PDF) Data Supplement Correction All Versions of this Article: 117/19/2492    most recent CIRCULATIONAHA.107.756809v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benn, M. Articles by Tybjærg-Hansen, A. Search for Related Content PubMed PubMed Citation Articles by Benn, M. Articles by Tybjærg-Hansen, A. Related Collections Clinical genetics Genetics of Stroke Epidemiology Genetics of cardiovascular disease Related Article

(Circulation. 2008;117:2492-2501.)
© 2008 American Heart Association, Inc.

Genetics

Mitochondrial Haplogroups

Ischemic Cardiovascular Disease, Other Diseases, Mortality, and Longevity in the General Population

Marianne Benn, MD, PhD; Marianne Schwartz, MSc, PhD; Børge G. Nordestgaard, MD, DMSc; Anne Tybjærg-Hansen, MD, DMSc

From the Departments of Clinical Biochemistry (M.B., A.T.-H.) and Clinical Genetics (M.S.), Rigshospitalet, Copenhagen University Hospital; Department of Clinical Biochemistry, Herlev University Hospital (B.G.N.); and the Copenhagen City Heart Study, Bispebjerg University Hospital (B.G.N., A.T.-H.); all Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Correspondence to Anne Tybjærg-Hansen, MD, DMSc, Department of Clinical Biochemistry KB3011, Section for Molecular Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark. E-mail at-h{at}rh.regionh.dk

Received November 30, 2007; accepted February 22, 2008.

Background— Rare mutations in the mitochondrial genome may cause disease. Mitochondrial haplogroups defined by common polymorphisms have been associated with risk of disease and longevity. We tested the hypothesis that common haplogroups predict risk of ischemic cardiovascular disease, morbidity from other causes, mortality, and longevity in a general population of European descent.

Methods and Results— We followed 9254 individuals from the Danish general population, in the Copenhagen City Heart Study, prospectively for risk of ischemic cardiovascular disease, morbidity from other causes, and mortality during 25 and 11 years, respectively. Haplogroup frequencies were as follows: H (45.9%), U (15.9%), T (9.9%), J (9.1), K (6.2%), V (4.5%), W/I (3.8%), and Z (3.5%). Hazard ratios for hospitalization due to all cardiovascular disorders (haplogroup U: 1.0 [95% confidence interval{CI}, 0.9 to 1.1]; T: 0.9 [95% CI, 0.8 to 1.0]; J: 1.0 [95% CI, 0.9 to 1.1]; K: 1.0 [95% CI, 0.9 to 1.2]; V: 1.0 [95% CI, 0.9 to 1.2]; W/I: 0.8 [95% CI, 0.7 to 1.0]; Z: 1.0 [95% CI, 0.8 to 1.2]), ischemic heart disease (U: 0.9 [95% CI, 0.8 to 1.1]; T: 0.9 [95% CI, 0.7 to 1.0]; J: 1.1 [95% CI, 0.9 to 1.2]; K: 1.1 [95% CI, 0.9 to 1.3]; V: 1.1 [95% CI, 0.9 to 1.4]; W/I: 1.1 [95% CI, 0.8 to 1.4]; Z: 1.1 [95% CI, 0.8 to 1.4]), and ischemic cerebrovascular disease (U: 1.1 [95% CI, 0.9 to 1.4]; T: 0.9 [95% CI, 0.7 to 1.2]; J: 1.1 [95% CI, 0.9 to 1.4]; K: 1.0 [95% CI, 0.8 to 1.4]; V: 1.1 [95% CI, 0.8 to 1.5]; W/I: 0.8 [95% CI, 0.5 to 1.3]; Z: 0.9 [95% CI, 0.6 to 1.4]) did not differ from 1.0 for any haplogroup versus the most common haplogroup H. Results were similar for hospitalization due to infectious and parasitic diseases, respiratory infections, respiratory disorders, malignant neoplasms, digestive disorders, musculoskeletal disorders, neuropsychiatric disorders, and miscarriages. Likewise, hazard ratios for death from all causes were not different from 1.0 for any haplogroup versus haplogroup H (U: 1.0 [95% CI, 0.8 to 1.1]; T: 0.9 [95% CI, 0.8 to 1.1]; J: 0.9 [95% CI, 0.8 to 1.1]; K: 1.0 [95% CI, 0.8 to 1.2]; V: 1.1 [95% CI, 0.9 to 1.3]; W/I: 0.8 [95% CI, 0.7 to 1.1]; Z: 0.9 [95% CI, 0.7 to 1.2]). Finally, after stratification by major causes of death, hazard ratios remained insignificant.

Conclusions— Our results do not support an association of mitochondrial haplogroups with risk of ischemic cardiovascular disease, morbidity from other causes, mortality, or longevity in a large general population of European descent.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 2425-2427. [Extract] [Full Text]

This article has been cited by other articles:

				R. S Bhopal and S. B Rafnsson Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations? Int. J. Epidemiol., August 1, 2009; 38(4): 1072 - 1081. [Abstract] [Full Text] [PDF]

				E. D. Michelakis Mitochondrial Medicine: A New Era in Medicine Opens New Windows and Brings New Challenges Circulation, May 13, 2008; 117(19): 2431 - 2434. [Full Text] [PDF]